The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bicycle Therapeutics Plc ADR shares valued at $71,499 were sold by Lee Kevin on Oct 03 ’24. At $22.26 per share, Lee Kevin sold 3,212 shares. The insider’s holdings dropped to 380,864 shares worth approximately $10.48 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hannay Michael Charles Ferguso sold 247 shares, netting a total of over 5,498 in proceeds. Following the sale of shares at $22.26 each, the insider now holds 22,398 shares.
Before that, Skynner Michael had sold 972 shares from its account. In a trade valued at $21,637, the CHIEF TECHNOLOGY OFFICER traded Bicycle Therapeutics Plc ADR shares for $22.26 each. Upon closing the transaction, the insider’s holdings decreased to 972 shares, worth approximately $2.56 million.
As published in their initiating research note from RBC Capital Mkts on September 06, 2024, Bicycle Therapeutics Plc ADR [BCYC] has been an Outperform and the price target has been revised to $35. Analysts at B. Riley Securities downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early August. As of September 11, 2023, B. Riley Securities has increased its “Neutral” rating to a “Buy” for BCYC. Earlier on August 31, 2022, Cowen initiated its rating. Their recommendation was “an Outperform” for BCYC stock.
Analyzing BCYC Stock Performance
During the last five days, there has been a surge of approximately 11.92%. Over the course of the year, Bicycle Therapeutics Plc ADR shares have jumped approximately 52.16%. Shares of the company reached a 52-week high of $28.67 on 10/16/24 and a 52-week low of $16.13 on 01/05/24. A 50-day SMA is recorded $23.63, while a 200-day SMA reached $22.45. Nevertheless, trading volume fell to 0.5 million shares from 0.43 million shares the previous day.
Support And Resistance Levels for Bicycle Therapeutics Plc ADR (BCYC)
According to the 24-hour chart, there is a support level at 26.86, which, if violated, would cause prices to drop to 26.20. In the upper region, resistance lies at 28.42. The next price resistance is at 29.32. RSI (Relative Strength Index) is 69.44 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.59, which suggests the price will increase in the coming days. Percent R is at 16.76%, indicating bullish price movement. Stochastics %K at selling indicates that the stock is to be held.
